SCHEMBL4765703

SCHEMBL4765703

CC(c1ccccc1)n1c(/C=C/c2cnn(Cc3ccccc3F)c2)c([N+](=O)[O-])c(=O)n(C(C)c2ccccc2)c1=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.36
ALDH1A1 P00352 4/20 0.36
PKM P14618 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
ADORA2A P29274 1/20 0.34
ADORA2B P29275 1/20 0.34
ADORA1 P30542 1/20 0.34
GAA P10253 1/20 0.34
CYP1A2 P05177 2/20 0.33
CYP2C19 P33261 2/20 0.33
PKLR P30613 1/20 0.33
POLB P06746 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
DCTPP1 Q9H773 1/20 0.33
GNRHR P30968 1/20 0.33
MAPK1 P28482 1/20 0.32
MITF O75030 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2C9 P11712 1/20 0.32
HDAC2 Q92769 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4765715 1.00 MAPT (0.36) MAPTALDH1A1PKML3MBTL1ADORA2A
SCHEMBL4771526 0.91 ADORA2A (0.34) MAPTALDH1A1PKML3MBTL1ADORA2A
SCHEMBL4763163 0.90 ADORA2A (0.37) MAPTALDH1A1ADORA2AADORA2BADORA1
SCHEMBL4763169 0.90 ADORA2A (0.37) MAPTALDH1A1ADORA2AADORA2BADORA1
SCHEMBL4764058 0.89 MAPT (0.37) MAPTALDH1A1PKML3MBTL1ADORA2A
SCHEMBL4764062 0.89 MAPT (0.37) MAPTALDH1A1PKML3MBTL1ADORA2A
SCHEMBL4763440 0.89 MAPT (0.33) MAPTALDH1A1PKML3MBTL1ADORA2A
SCHEMBL4763444 0.89 MAPT (0.33) MAPTALDH1A1PKML3MBTL1ADORA2A
SCHEMBL4771433 0.88 MAPT (0.38) MAPTALDH1A1PKML3MBTL1ADORA2A
SCHEMBL4771422 0.88 MAPT (0.38) MAPTALDH1A1PKML3MBTL1ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678181-B1 A2B ADENOSINE RECEPTOR ANTAGONISTS CV THERAPEUTICS INC (US) 2008-12-31 EP disclosed